Blaine Labs Inc

Santa Fe Springs, CA, United States

1

Total Recalls

1

Class I Recalls

0

Ongoing Recalls

Recalls by Blaine Labs Inc

FDA Drug Class I Terminated

REVITADERM WOUND CARE GEL, (Benzalkonium Chloride in a gel containing transforming growth factor-b), 0.1%, packaged in 29.6 mL (1.0 FL OZ) bottles (NDC 63347-120-02) and 88.7 mL (3.0 FL OZ) tubes (NDC

January 25, 2022 Blaine Labs Inc 1119 (1 oz.) bottles/ 772 (3 oz.) tubes units